Verified peer comparison
Prospect Capital vs Adaptive Biotechnologies Financial Comparison
Direct answer
Prospect Capital and Adaptive Biotechnologies are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Prospect Capital email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Prospect Capital Revenue
- -276,828,000 USD
- Adaptive Biotechnologies Revenue
- 276,976,000 USD
- Prospect Capital Operating income
- -469,924,000 USD
- Adaptive Biotechnologies Operating income
- -57,123,000 USD